Gw Pharmaceuticals Plc (GWPH)

Trade GWPH now with
11/27/2018 4:05:19 PM GW Pharmaceuticals Q4 Loss/share $0.23 Vs. Loss $0.18 Year Ago
11/26/2018 7:03:13 AM GW Pharma Announces Second Positive Phase 3 Pivotal Trial For EPIDIOLEX Oral Solution CV For Dravet Syndrome
11/1/2018 6:54:02 AM GW Pharma Says EPIDIOLEX Oral Solution Now Available By Prescription In The U.S.
10/2/2018 8:33:22 PM GW Pharma Announces Pricing Of Public Offering Of ADSs Raising Gross Proceeds Of $300 Mln
9/27/2018 9:28:11 AM GW Pharmaceuticals Announce DEA Has Rescheduled EPIDIOLEX Oral Solution To Schedule V
7/16/2018 6:47:42 AM New Drugs Approved In June
4/12/2018 7:14:37 AM GW Pharmaceuticals And U.S. Subsidiary Greenwich Biosciences To Present Data On Epidiolex At AAN
2/27/2018 7:08:54 AM GW Pharmaceuticals Receives Orphan Drug Designation From EMA For Cannabidiol For Treatment Of Tuberous Sclerosis